Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the present study is to prospectively assess the anti-depressant effectiveness of
reboxetine in children and adolescents, as compared with fluoxetine, in a randomized
controlled open-label trial.